Literature DB >> 17397490

European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.

H G Wiener1, P Klinkhamer, U Schenck, M Arbyn, J Bulten, C Bergeron, A Herbert.   

Abstract

The quality of a cervical cytology laboratory depends on adequate handling and staining of the samples, screening and interpretation of the slides and reporting of the results. These guidelines give an overview of procedures recommended in Europe to manage the balance between best patient care possible, laboratory quality assurance and cost effectiveness and will be published as a chapter 4 in the European Guidelines for Quality Assurance in Cervical Cancer Screening. The laboratory guidelines include protocols for personnel and organisation, material requirements, handling and analysing cervical samples, recording of results, quality management and communication. The section on quality management is comprehensive and includes protocols for all aspects of internal and external quality assurance. The guidelines are extensively referenced and as far as possible the recommendations are evidence-based.

Entities:  

Mesh:

Year:  2007        PMID: 17397490     DOI: 10.1111/j.1365-2303.2007.00451.x

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  6 in total

1.  European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document.

Authors:  M Arbyn; A Anttila; J Jordan; G Ronco; U Schenck; N Segnan; H Wiener; A Herbert; L von Karsa
Journal:  Ann Oncol       Date:  2010-03       Impact factor: 32.976

2.  Early detection of cervical carcinomas: finding an overall approach.

Authors:  Nicolas Wentzensen; Stefanie J Klug
Journal:  Dtsch Arztebl Int       Date:  2008-09-12       Impact factor: 5.594

3.  The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.

Authors:  Andrzej Nowakowski; Marek Cybulski; Andrzej Śliwczyński; Arkadiusz Chil; Zbigniew Teter; Przemysław Seroczyński; Marc Arbyn; Ahti Anttila
Journal:  BMC Cancer       Date:  2015-04-14       Impact factor: 4.430

4.  Impact of sex, body mass index and initial pathologic diagnosis age on the incidence and prognosis of different types of cancer.

Authors:  Xuan Huang; Chuanjun Shu; Li Chen; Bing Yao
Journal:  Oncol Rep       Date:  2018-06-27       Impact factor: 3.906

5.  Conventional Microscopical versus Digital Whole-Slide Imaging-Based Diagnosis of Thin-Layer Cervical Specimens: A Validation Study.

Authors:  Odille Bongaerts; Carla Clevers; Marij Debets; Daniëlle Paffen; Lisanne Senden; Kim Rijks; Linda Ruiten; Daisy Sie-Go; Paul J van Diest; Marius Nap
Journal:  J Pathol Inform       Date:  2018-08-27

6.  Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.

Authors:  Dongman Zhao; Liran Zhang; Fengxiang Xie; Dezhi Peng; Jie Wei; Lingbo Jiang; Shoudu Zhang; Debo Qi
Journal:  BMC Cancer       Date:  2020-08-26       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.